Skip to main content

Tweets

🔎Long-term malignancy risk remains an important consideration in RA treatment See the SELECT trial program 5-year malignancy risk data for a JAKi and TNFi in RA, including in high CV-risk patients: https://t.co/1PBrCKLRan Sponsored by AbbVie Medical Affairs + Health https://t.co/xyRGCz4K9i
Dr. John Cush @RheumNow ( View Tweet )
17 minutes 9 seconds ago
Top 6 Practice-Changing Highlights from ACR26 The content at ACR Orlando was vast. We looked at several posters/listened to many talks, and heard from colleagues. So if we missed some great abstracts that will be practice-changing for you, we apologize in advance. Here is our https://t.co/JmRpPh8Wzi
Dr. John Cush @RheumNow ( View Tweet )
1 hour ago
Does a Gout Flare Increase Risk of a Cardiovascular Event? In 2022, Cipolletta and colleagues published a JAMA study showing a temporal association between gout flares and subsequent major adverse cardiovascular events (MACE). This study reported 93% higher odds of MACE in the https://t.co/G91c9oz7tP
Dr. John Cush @RheumNow ( View Tweet )
2 hours 17 minutes ago
Who benefits from GLP-1s in your rheumatology clinic? Hear Dr. Catherine Bakewell tackle that question on Jan 30 at https://t.co/9THCAABeZ0. Kick off 2027 with rheumatology CME Jan 30–31 in Irving, TX, or live online. Early-bird pricing through Dec 15. https://t.co/xjuAWKqAY9 https://t.co/9Nwx85xIb6
Dr. John Cush @RheumNow ( View Tweet )
3 hours 48 minutes ago
Low PREVENT Score, Real Risk: Coronary Calcium and Heart Failure in Lupus Dr. Akhil Sood | Abstracts 2861 0922 | ACR 2026 https://t.co/hREBmSbDQK https://t.co/wuiriT45zs
Dr. John Cush @RheumNow ( View Tweet )
5 hours ago
Who gets left behind by the new SpA Criteria Dr. Henrique Dalmolin & Dr. Carla Saad & Dr. Licia Mota | ACR 2026 https://t.co/SJhUVCZ8aZ https://t.co/vpe7ASo82Q
Dr. John Cush @RheumNow ( View Tweet )
19 hours 19 minutes ago
Biologics vs JAKi: MACE and VTE Risk in PsA Dr. Sheila Reyes & Dr. Marina Magrey | Abstract 2304 | ACR 2026 https://t.co/IzafHHg9Me https://t.co/PGfQOk882R
Dr. John Cush @RheumNow ( View Tweet )
20 hours 19 minutes ago
JAKi CV Safety in Younger Adults https://t.co/Cp7YEz0277 https://t.co/oBGRQjBuoH
Dr. John Cush @RheumNow ( View Tweet )
20 hours 48 minutes ago
UPSTAND study: widespread pain responding to JAK inhibition https://t.co/ZGouZSXaXU https://t.co/He2nXncsFF
Dr. John Cush @RheumNow ( View Tweet )
22 hours 19 minutes ago
Who might benefit from GLP-1s in your rheumatology clinic? Join Drs. Catherine Bakewell and Leonard Calabrese at https://t.co/9THCAABeZ0, Jan 30–31 in Dallas, TX, or live online. Kick off 2027 with 12.5 CME credits. Early bird pricing through Dec 15. https://t.co/xjuAWKqAY9 https://t.co/xhqg94lmoy
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Pioneers & Progress in Pediatric Rheumatology: The 50th Anniversary Dr. Susan Shenoi | "Mastering the Field of Pediatric Rheumatology: Pioneers and Progress, 50th Anniversary" |ACR 2026 https://t.co/hSx8LHR99s https://t.co/cQNLQkT6qp
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Not All Pain in Rheumatic Disease is Inflammatory In a session at the Global Rheumatology Summit, Dr. Daniel Clauw, an expert on the topic, explained that fibromyalgia can occur in isolation in a “top-down” fashion, or can be secondary to inflammatory autoimmune diseases in a https://t.co/AMUm52SKsB
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Points to Consider in D2M/Treatment Refractory axSpA New ASAS guidance presented at #ACR26 outlines 10 points to consider, from diagnostic reassessment to inflammation, mimics & treatment adherence. Dr. Sheila Reyes breaks it down: https://t.co/vvT2qWbbM7 https://t.co/Crf5uisIvS
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
To Pulse or Not to Pulse in ANCA Associated Vasculitis? New #ACR26 data found no significant remission benefit with pulse steroids, but serious infections were higher (31% vs 14%). Is it time to rethink their use? Dr. Michael Putman weighs in: https://t.co/b6cJkI2aXc https://t.co/rM3eoRBJYW
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
What does CAR-T safety look like between autoimmune disease and heme-onc? Here's CRS and ICANS within the cohorts so far (although don't forget about the lymphodepletion) Anca Askanase @HSpecialSurgery #ACR26 @RheumNow https://t.co/GkDGDiOET4
David Liew @drdavidliew ( View Tweet )
1 day ago
×